EGFR and HER2 expression in advanced biliary tract cancer.

Jan Harder,Oliver Waiz,Florian Otto,Michael Geissler,Manfred Olschewski,Brigitte Weinhold,Hubert E. Blum,Annette Schmitt-Graeff,Oliver G. Opitz

EGFR and HER2 expression in advanced biliary tract cancer.

2009

Jan Harder
Oliver Waiz
Florian Otto
Michael Geissler
Manfred Olschewski
Brigitte Weinhold
Hubert E. Blum
Annette Schmitt-Graeff
Oliver G. Opitz

CONCLUSION: Our data suggest that routine testing and therapeutic targeting of HER2 does not seem to be useful in patients with BTC, while targeting EGFR may be promising.

Keywords:

Cancer
General surgery
Targeted therapy
Biliary tract
Gallbladder cancer
Diabetes mellitus
Medicine
Chemotherapy
Pathology
Biopsy
Immunochemistry
Gastroenterology
Internal medicine
Epidermal growth factor receptor
Immunohistochemistry

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations